Exsure Secures ₹3 Crore Seed Funding to Revolutionize Cancer Treatment
Exsure, a pioneering biotech startup, has raised ₹3 crore in a seed funding round led by Unicorn India Ventures. The funding will expedite the completion of non-clinical studies for Exsure’s patented exosome-based drug delivery technology, aimed at minimizing the side effects and toxicity of chemotherapy. Additionally, the funds will support global expansion and the development … Read more